The use of scalp hypothermia in the prevention of doxorubicin-induced hair loss
Authors:
Abstract
A randomized clinical trial was performed to determine the effectiveness of scalp hypothermia in the prevention of hair loss associated with doxorubicin. Twenty-six patients were randomized to receive scalp hypothermia or chemotherapy alone. Data were analyzed on 25 patients: 12 in the treatment group and 13 in the control group. There was acceptable hair preservation in 75% of the patients who received the scalp hypothermia; only 8% of the patients in the control group had acceptable hair preservation (P = 0.0009). The data were further broken down into patients receiving low-dose doxorubicin and high-dose doxorubicin. Side effects were minimal. The results support the use of scalp hypothermia in reducing doxorubicin-induced alopecia.Keywords
This publication has 6 references indexed in Scilit:
- Prevention of doxorubicin-induced alopecia by scalp cooling in patients with advanced breast cancer.BMJ, 1981
- Prevention of Doxorubicin-Induced Hair Loss with Scalp HypothermiaNew England Journal of Medicine, 1979
- DOXORUBICIN-INDUCED HAIR LOSS AND POSSIBLE MODIFICATION BY SCALP COOLINGThe Lancet, 1977
- Adriamycin—A ReviewJNCI: Journal of the National Cancer Institute, 1975
- AdriamycinAnnals of Internal Medicine, 1974
- Variation of the supercoils in closed circular DNA by binding of antibiotics and drugs: Evidence for molecular models involving intercalationJournal of Molecular Biology, 1970